评估2019年新冠肺炎的急性肺部变化:对相关模式的比较分析
Ian Griffin1, Ronak Kundalia1, Bruce Steinberg1
1College of Medicine, University of Florida, Gainesville, FL.
Seminars in ultrasound, CT, and MR
|March 1, 2024
概括
本综述强调了医学成像在评估2019年冠状病毒疾病 (COVID-19) 中的作用. 高分辨率计算机断层扫描和肺部超声波是检测肺部异常和指导关键护理决策的关键工具.
科学领域:
- 放射学 放射学是指放射学
- 医疗成像医学成像
- 肺部病理学 肺部病理学
背景情况:
- 冠状病毒疾病2019 (COVID-19) 在急性阶段提出了诊断挑战.
- 图像对评估COVID-19肺部感染的严重程度和程度起着至关重要的作用.
- 了解不同成像方式的细微差别对于有效的患者管理至关重要.
研究的目的:
- 审查各种成像技术在COVID-19急性评估中的实用性.
- 讨论与COVID-19相关的典型和非典型成像研究结果.
- 强调COVID-19患者成像发现的预后价值.
主要方法:
- 关于COVID-19中医学成像的当前文献的审查.
- 分析高分辨率计算机断层扫描 (HRCT),胸部放射 (CR),肺部超声波 (LUS) 和磁共振成像 (MRI) 的研究结果.
- 讨论成像特征及其与疾病严重程度和结果的相关性.
主要成果:
- 高分辨率计算机断层扫描 (HRCT) 对检测COVID-19肺部异常非常敏感.
- 胸部放射 (CR) 在早期具有有限的效用,但可以在以后显示变化.
- 肺部超声波 (LUS) 在重症监护机构提供无辐射的替代方案,而MRI显示了潜在的可能性.
- 图像检测结果具有显著的预后价值,有助于患者分层.
结论:
- 建议采用多式成像方法进行全面的COVID-19评估.
- 急性阶段的放射性诊断需要仔细解释,考虑到典型和非典型的表现.
- 图像检测结果,特别是来自HRCT和LUS,对于指导治疗和预测COVID-19的结果至关重要.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Acute Respiratory Failure-V
138
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
138
Pneumonia III: Complications and Assessment
209
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
209
Pneumonia IV: Management
324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


